Levetiracetam
NDC 65862-250, Levetiracetam, solution, from Aurobindo Pharma Limited.
- Product NDC
- 65862-250
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM100 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-250-05 | 65862025005 | 500 mL in 1 BOTTLE, PLASTIC (65862-250-05) |
| 65862-250-47 | 65862025047 | 473 mL in 1 BOTTLE, PLASTIC (65862-250-47) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f65ec19d-b90e-452e-b761-c68b1cf2c892NADAC price for package 65862025047
GET /v1/drugs/nadac/65862025047
Use it
Look up 65862-250 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.